ORBERA INTRAGASTRIC BALLOON SYSTEM
Report
- Report Number
- 3006722112-2016-00345
- Event Type
- Injury
- Date Received
- November 22, 2016
- Date of Event
- October 14, 2016
- Report Date
- October 25, 2016
- Manufacturer
- APOLLO ENDOSURGERY, INC.
- Product Code
- LTI
- PMA / PMN Number
- P140008
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- UK
- Reporter Occupation
- PHYSICIAN
Narratives
MEDWATCH SENT TO THE FDA ON 11/22/2016. THE REPORTER OF THE EVENT WAS ASKED TO RETURN THE PRODUCT FOR ANALYSIS, AND TO INDICATE PRODUCT SERIAL NUMBER. TO DATE, NEITHER THE DEVICE NOR ANY FURTHER DEVICE INFORMATION HAS BEEN RECEIVED BY APOLLO. DEVICE LABELING ADDRESSES THE REPORTED EVENT AS FOLLOWS: WARNINGS AND PRECAUTIONS: THE PHYSIOLOGICAL RESPONSE OF THE PATIENT TO THE PRESENCE OF THE ORBERA SYSTEM BALLOON MAY VARY DEPENDING UPON THE PATIENT'S GENERAL CONDITION AND THE LEVEL AND TYPE OF ACTIVITY. THE TYPES AND FREQUENCY OF ADMINISTRATION OF DRUGS OR DIET SUPPLEMENTS AND THE OVERALL DIET OF THE PATIENT MAY ALSO AFFECT THE RESPONSE. EACH PATIENT MUST BE MONITORED CLOSELY DURING THE ENTIRE TERM OF TREATMENT IN ORDER TO DETECT THE DEVELOPMENT OF POSSIBLE COMPLICATIONS. EACH PATIENT SHOULD BE INSTRUCTED REGARDING SYMPTOMS OF DEFLATION, GASTROINTESTINAL OBSTRUCTION, ULCERATION AND OTHER COMPLICATIONS WHICH MIGHT OCCUR, AND SHOULD BE ADVISED TO CONTACT HIS/HER PHYSICIAN IMMEDIATELY UPON THE ONSET OF SUCH SYMPTOMS.
REPORTED AS: A PATIENT WITH THE ORBERA INTRAGASTRIC BALLOON HAD "THE BALLOON REMOVED SURGICALLY DUE TO NECROSIS OF PART OF THE FUNDUS. PATIENT HAD TO HAVE A GASTRIC RESECTION AS A RESULT."
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 771636 | ORBERA INTRAGASTRIC BALLOON SYSTEM | INTRAGASTRIC BALLOON | LTI | APOLLO ENDOSURGERY, INC. | B-50000 | NI |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Required Intervention |